1. US Food and Drug Administration. Inclusion of older adults in cancer clinical trials; guidance for industry. 2022. Available from: https://www.fda.gov/media/156616/download. [Accessed 17 Apr 2024].
2. Liu Q, Schwartz JB, Slattum PW, Lau SWJ, Guinn D, Madabushi R, et al. Roadmap to 2030 for drug evaluation in older adults. Clin Pharmacol Ther. 2022;112(2):210–23. https://doi.org/10.1002/cpt.2452. (Epub 2021 Nov 8 PMID: 34656074).
3. US Food and Drug Administration. Geriatric information in human prescription drug and biological product labeling guidance for industry. Draft guidance for industry. 2020. Available from: https://www.fda.gov/regulatory-information/search-fda-guidance-documents/geriatric-information-human-prescription-drug-and-biological-product-labeling-guidance-industry. [Accessed 17 Apr 2024].
4. US Administration for Community Living. 2020 profile of older Americans. 2021. Available from: https://acl.gov/sites/default/files/Aging%20and%20Disability%20in%20America/2020ProfileOlderAmericans.Final_.pdf. [Accessed 17 Apr 2024].
5. Scottish Government Polypharmacy Model of Care Group. Polypharmacy guidance, realistic prescribing. 3rd Edition. 2018. Scottish Government https://www.therapeutics.scot.nhs.uk/wp-content/uploads/2018/09/Polypharmacy-Guidance-2018.pdf. [Accessed 17 Apr 2024].